Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18537882
[patent_doc_number] => 20230242985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD AND KIT FOR DETERMINING THE TISSUE OR CELL ORIGIN OF DNA
[patent_app_type] => utility
[patent_app_number] => 18/169821
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169821 | METHOD AND KIT FOR DETERMINING THE TISSUE OR CELL ORIGIN OF DNA | Feb 14, 2023 | Pending |
Array
(
[id] => 17156487
[patent_doc_number] => 20210317538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => DETECTING PANCREATIC HIGH-GRADE DYSPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/347027
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347027 | DETECTING PANCREATIC HIGH-GRADE DYSPLASIA | Jun 13, 2021 | Pending |
Array
(
[id] => 17112256
[patent_doc_number] => 20210292853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/336935
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336935 | DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER | Jun 1, 2021 | Pending |
Array
(
[id] => 18170602
[patent_doc_number] => 20230037213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/783664
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783664 | CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF | Jun 1, 2021 | Pending |
Array
(
[id] => 17482701
[patent_doc_number] => 20220090205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE
[patent_app_type] => utility
[patent_app_number] => 17/335526
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335526 | METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE | May 31, 2021 | Pending |
Array
(
[id] => 17274857
[patent_doc_number] => 20210381055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS OF DETECTING AND TREATING MULTIPLE SYSTEM ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/334683
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334683
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334683 | METHODS OF DETECTING AND TREATING MULTIPLE SYSTEM ATROPHY | May 27, 2021 | Pending |
Array
(
[id] => 18837927
[patent_doc_number] => 11845990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
[patent_app_type] => utility
[patent_app_number] => 17/327102
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 3917
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327102 | Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype | May 20, 2021 | Issued |
Array
(
[id] => 17067643
[patent_doc_number] => 20210269858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/319907
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319907
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319907 | METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID | May 12, 2021 | Pending |
Array
(
[id] => 16992253
[patent_doc_number] => 20210230673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/228749
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228749 | ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS | Apr 12, 2021 | Pending |
Array
(
[id] => 16992189
[patent_doc_number] => 20210230609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/225405
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225405 | Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof | Apr 7, 2021 | Pending |
Array
(
[id] => 17007534
[patent_doc_number] => 20210238695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHODS OF MAST CELL TUMOR PROGNOSIS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/216170
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216170 | METHODS OF MAST CELL TUMOR PROGNOSIS AND USES THEREOF | Mar 28, 2021 | Pending |
Array
(
[id] => 16948533
[patent_doc_number] => 20210207224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => DETECTING BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/205796
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205796 | DETECTING BREAST CANCER | Mar 17, 2021 | Pending |
Array
(
[id] => 16932862
[patent_doc_number] => 20210198751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/204227
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204227 | COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID | Mar 16, 2021 | Pending |
Array
(
[id] => 16978026
[patent_doc_number] => 20210222263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => CROSS-ASSEMBLY PHAGE DNA SEQUENCES, PRIMERS AND PROBES FOR PCR-BASED IDENTIFICATION OF HUMAN FECAL POLLUTION SOURCES
[patent_app_type] => utility
[patent_app_number] => 17/201403
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201403 | CROSS-ASSEMBLY PHAGE DNA SEQUENCES, PRIMERS AND PROBES FOR PCR-BASED IDENTIFICATION OF HUMAN FECAL POLLUTION SOURCES | Mar 14, 2021 | Pending |
Array
(
[id] => 16978019
[patent_doc_number] => 20210222256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/179990
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179990 | PANCREATIC CANCER | Feb 18, 2021 | Pending |
Array
(
[id] => 16885832
[patent_doc_number] => 20210172027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => DETECTING BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/178110
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178110 | DETECTING BREAST CANCER | Feb 16, 2021 | Pending |
Array
(
[id] => 16901220
[patent_doc_number] => 20210180136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/248798
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248798 | Compositions and methods for diagnosis and treatment of epilepsy | Feb 7, 2021 | Issued |
Array
(
[id] => 19258292
[patent_doc_number] => 12018338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions and methods for detection of
[patent_app_type] => utility
[patent_app_number] => 17/155831
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11992
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155831 | Compositions and methods for detection of | Jan 21, 2021 | Issued |
Array
(
[id] => 17272801
[patent_doc_number] => 20210378999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS FOR TREATING NEUROBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 17/147697
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147697 | METHODS FOR TREATING NEUROBLASTOMA | Jan 12, 2021 | Abandoned |
Array
(
[id] => 16728199
[patent_doc_number] => 20210095346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => METHOD TO PREDICT HERITABLE CANINE NON-CONTACT CRUCIATE LIGAMENT RUPTURE
[patent_app_type] => utility
[patent_app_number] => 17/112608
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112608 | METHOD TO PREDICT HERITABLE CANINE NON-CONTACT CRUCIATE LIGAMENT RUPTURE | Dec 3, 2020 | Pending |